Literature DB >> 10212012

Prokinetic agents for the treatment of postoperative ileus in adults: a review of the literature.

T J Bungard1, P B Kale-Pradhan.   

Abstract

Metoclopramide, cisapride, and erythromycin are commonly administered to reduce the duration of postoperative ileus (POI). As these agents are not without potential adverse effects, their efficacy in shortening the duration of POI should be evaluated. The etiology of POI is not well understood and therefore the precise treatment is unclear. Nasogastric suction is the mainstay of therapy, and management of fluid and electrolyte imbalances is crucial. The role of prokinetic agents is less understood. Available literature evaluating these drugs specifically for POI were reviewed, but results are confounded by issues such as sample size, variability in types of operations performed, and insensitive end points (flatus, bowel sounds). No literature supports reducing the duration of POI with metoclopramide, and limited data show benefit with cisapride. Data evaluating erythromycin are sparse, and the drug is believed to be ineffective. Domperidone, a prokinetic agent not available in the United States, has not been evaluated in POI. Due to these limitations, treatment remains largely supportive with a limited role for prokinetic agents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10212012     DOI: 10.1592/phco.19.6.416.31040

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  18 in total

Review 1.  Postoperative ileus.

Authors:  H Kehlet
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 2.  Postoperative ileus: progress towards effective management.

Authors:  Kathrine Holte; Henrik Kehlet
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Acute Intestinal Pseudo-obstruction.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-08

Review 4.  Postoperative ileus: impact of pharmacological treatment, laparoscopic surgery and enhanced recovery pathways.

Authors:  Knut Magne Augestad; Conor P Delaney
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

Review 5.  Review of the pathophysiology and management of postoperative ileus.

Authors:  Peter Mattei; John L Rombeau
Journal:  World J Surg       Date:  2006-08       Impact factor: 3.352

Review 6.  Improvements in safety and recovery following cystectomy: reassessing the role of pre-operative bowel preparation and interventions to speed return of post-operative bowel function.

Authors:  Harras B Zaid; Samuel D Kaffenberger; Sam S Chang
Journal:  Curr Urol Rep       Date:  2013-04       Impact factor: 3.092

7.  Capsule endoscopy: improving transit time and image view.

Authors:  Zvi Fireman; D Paz; Y Kopelman
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

8.  Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study.

Authors:  E R Viscusi; S Goldstein; T Witkowski; A Andonakakis; R Jan; K Gabriel; W Du; L Techner; B Wallin
Journal:  Surg Endosc       Date:  2005-12-07       Impact factor: 4.584

9.  Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus.

Authors:  Bruce G Wolff; Fabrizio Michelassi; Todd M Gerkin; Lee Techner; Kathie Gabriel; Wei Du; Bruce A Wallin
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

10.  Effect of bisacodyl on postoperative bowel motility in elective colorectal surgery: a prospective, randomized trial.

Authors:  U Zingg; D Miskovic; I Pasternak; P Meyer; C T Hamel; U Metzger
Journal:  Int J Colorectal Dis       Date:  2008-07-30       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.